Skip to main content
Terug
Watch Compare

Orthofix Medical Inc.

Datakwaliteit: 100%
OFIX
NASDAQ Manufacturing Measuring & Analyzing Instruments
€ 12,38
▼ € 0,04 (-0,32%)
Marktkapitalisatie: 501,40 M
Prijs
€ 12,49
Marktkapitalisatie
501,40 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Revenue grew 15,35% annually over 5 years — strong growth
Debt/Equity of 0,36 — conservative balance sheet
Generating 33,35 M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 12,50%

Groei

Revenue Growth (5Y)
15,35%
Boven sectorgemiddelde (1,92%)
Revenue (1Y)2,85%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-20,47%
Boven sectorgemiddelde (-54,44%)
ROIC-9,45%
Net Margin-11,21%
Op. Margin-9,90%

Veiligheid

Debt / Equity
0,36
Boven sectorgemiddelde (0,30)
Current Ratio2,47
Interest Coverage-4,66

Waardering

PE (TTM|NTM|2027)
-5,44 | 14,48 | 14,61
Onder sectorgemiddelde (-1,49)
P/B Ratio1,13
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1385 peers)
Metriek Aandeel Sector Mediaan
P/E -5,4 -1,5
P/B 1,1 1,6
ROE % -20,5 -54,4
Net Margin % -11,2 -41,5
Rev Growth 5Y % 15,4 1,9
D/E 0,4 0,3

Koersdoel Analisten

4 analisten
Buy
Huidig
€ 12,38
+39.3%
Koersdoel
€ 17,25
€ 14,00
€ 17,50
€ 20,00
Vooruitzicht
Forward K/W 14,48
Forward WPA € 0,86
WPA Groei (sch.) +470,0%
Omzet Sch. 908,82 M

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 € 0,86
€ 0,32 – € 1,39
 908,82 M 2
FY2026 € 0,15
€ 0,15 – € 0,15
 855,61 M 1

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 € 0,42 € 0,24 -42,7%
Q32025 € 0,12 € 0,20 +64,7%
Q22025 € 0,04 € 0,13 +223,5%
Q12025 -€ 0,27 -€ 0,03 +88,0%

ETFs Holding This Stock

WESCX WESCX
1,73% weight
WWSAX WWSAX
1,73% weight
LFSC logo LFSC F/M Emerald Life Sciences Innovation ETF
0,83% weight
VYSAX VYSAX
0,32% weight
VYSYX VYSYX
0,32% weight
VYSGX VYSGX
0,32% weight
VYSDX VYSDX
0,32% weight
VYSZX VYSZX
0,32% weight
VYSEX VYSEX
0,32% weight
IASCX IASCX
0,29% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 2,85% Revenue Growth (3Y) 4,95%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 15,35% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 822,31 M Net Income (TTM) -92,19 M
ROE -20,47% ROA -11,04%
Gross Margin 68,83% Operating Margin -9,90%
Net Margin -11,21% Free Cash Flow (TTM) 33,35 M
ROIC -9,45% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,36 Current Ratio 2,47
Interest Coverage -4,66 Asset Turnover 0,98
Working Capital 234,32 M Tangible Book Value 171,91 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -5,44 Forward P/E 14,48
P/B Ratio 1,13 P/S Ratio 0,61
PEG Ratio N/A Forward PEG 0,03
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 0,55 Fwd Earnings Yield 6,91%
FCF Yield 6,65%
Market Cap 501,40 M Enterprise Value 595,76 M
Per Share
EPS (Diluted TTM) -2,33 Revenue / Share 20,48
FCF / Share 0,83 OCF / Share 0,83
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion -36,17%
SBC-Adj. FCF 5,34 M Growth Momentum -12,50

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 822,31 M 799,49 M 746,64 M 460,71 M 464,48 M
Net Income -92,19 M -126,00 M -151,40 M -19,75 M -38,38 M
EPS (Diluted) -2,33 -3,30 -4,12 -0,98 -1,95
Gross Profit 566,02 M 545,89 M 486,27 M 337,17 M 349,57 M
Operating Income -81,43 M -84,62 M -139,11 M -13,27 M -8,32 M
EBITDA — — — — —
R&D Expenses 65,85 M 73,64 M 80,23 M 49,07 M 49,62 M
SG&A Expenses 554,33 M 532,53 M — — —
D&A 77,32 M 60,06 M 53,06 M 29,02 M 29,60 M
Interest Expense -17,49 M -29,63 M -8,63 M -1,29 M -1,84 M
Income Tax 1,38 M 2,12 M 2,72 M 2,04 M 24,88 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 850,65 M 893,29 M 925,32 M 458,63 M 476,62 M
Total Liabilities 400,61 M 390,17 M 326,59 M 121,77 M 139,69 M
Shareholders' Equity 450,04 M 503,12 M 598,73 M 336,86 M 336,93 M
Total Debt 157,39 M 157,02 M 94,36 M — —
Cash & Equivalents 82,03 M 83,24 M 33,11 M 50,70 M 87,85 M
Current Assets 416,85 M 433,29 M 420,44 M 255,99 M 269,52 M
Current Liabilities 170,48 M 168,63 M 165,22 M 83,62 M 105,83 M